Progress in construction of hypoxia-sensitive CAR-T cell for solid tumor therapy
Chimeric antigen receptor T (CAR-T) cell therapy, as a kind of tumor immunotherapy, has made remarkable achievements for the treatment of hematological malignancy. Disappointingly, regarding solid tumors, CAR-T cells generally target tumor-associated antigens that are also widely expressed in normal...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2023-01-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1676258293239-942499708.pdf |